Eutropics Pharmaceuticals
PrivateLast Round
Early Stage
VC
Jan 11, 2024
Total Funding Raised
$10.6M
Company Overview
Eutropics Pharmaceuticals is a biotechnology company that develops predictive diagnostic biomarker technology designed to guide cancer treatment decisions by measuring protein-protein interactions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Eutropics Pharmaceuticals Comparables
Compare Eutropics Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kiyatec | 85% | |
| Travera | 84% | |
| SageMedic Corp. | 83% |
Eutropics Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Stage VC | Jan 11, 2024 | ||||
| Grant | Aug 27, 2019 | ||||
| Grant | Jun 1, 2019 | ||||
| Grant | Sep 1, 2018 | ||||
| Grant | Sep 1, 2017 | ||||
Grant | Sep 18, 2012 |
Eutropics Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| MassVentures | Grant |
| Massachusetts Life Sciences Center | Accelerator |
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 11, 2024
Raised an early stage VC round.
- Aug 27, 2019
$1.5M grant awarded by the National Cancer Institute.
Eutropics Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Eutropics Pharmaceuticals's valuation, stock price, and market status.
Is Eutropics Pharmaceuticals a public or private company?
Eutropics Pharmaceuticals is a private company.
What is the current stock price of Eutropics Pharmaceuticals?
Eutropics Pharmaceuticals is a private company with no public stock price. No recent secondary market data is available.
How much is Eutropics Pharmaceuticals worth (valuation)?
Valuation information for Eutropics Pharmaceuticals is not publicly available.
Can I buy Eutropics Pharmaceuticals stock?
Eutropics Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Eutropics Pharmaceuticals's last funding round?
Eutropics Pharmaceuticals's most recent funding round was Early Stage VC on January 11, 2024.
Who are the main investors in Eutropics Pharmaceuticals?
Key investors in Eutropics Pharmaceuticals include National Cancer Institute, MassVentures, Massachusetts Life Sciences Center.
Will Eutropics Pharmaceuticals IPO soon?
No public IPO plans have been announced for Eutropics Pharmaceuticals.
How can I track Eutropics Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Eutropics Pharmaceuticals's secondary market activity and sign up for updates.